Loading...

Loading...

mRNA: From COVID Vaccine Savior to Cancer's Next Cure
By Luis Alberto Velez - Fri, 10/31/2025 - 08:00
mRNA is a paradigm shift, transforming how we think about treatment, prevention, and personalization in medicine, writes Luis Velez.
https://mexicobusiness.news/tag/moderna
More Health
FDA Approves Updated COVID-19 Vaccines for Fall Campaign
By Anmol Motwani - Wed, 08/28/2024 - 17:03
The FDA approves updated COVID-19 vaccines from Pfizer and Moderna targeting the KP.2 variant, aiming to bolster protection against severe symptoms.

Exercise on the Spotlight: The Week in Health
By Sofía Garduño - Thu, 08/01/2024 - 10:00
The WHO is taking action to enhance health security during the Paris Olympics, while experts point to the benefits of exercise during menopause.

BARDA Awards Moderna US$176 Million for Avian Flu Vaccine
By MBN Staff - Thu, 07/25/2024 - 10:20
BARDA’s US$176 million grant to Moderna accelerates mRNA avian flu vaccine development, enhancing rapid-response amid rising outbreak concerns.

Colorado Reports First Human Avian Flu Case Amid New Strains
By Anmol Motwani - Wed, 07/10/2024 - 09:41
Colorado's first human avian flu case follows outbreaks in 139 US farms. New H7N5 strain emerges in Germany, raising pandemic concerns.

Dengue, STSS in the Spotlight: The Week in Health
By Sofía Garduño - Thu, 06/20/2024 - 09:40
Scientists in Morelos are deploying a dengue prevention program. Meanwhile, Japan faces a surge of Streptococcal Toxic Shock Syndrome (STTS).
Moderna's Next-Gen COVID-19 Vaccine Shows Promise
By MBN Staff - Tue, 06/18/2024 - 10:48
Moderna's next-gen COVID-19 vaccine, mRNA-1283, shows non-inferior efficacy and may ease distribution challenges.

FDA Approves Moderna's RSV Vaccine
By Anmol Motwani - Mon, 06/03/2024 - 09:28
The US FDA approved Moderna's mResvia for adults over 60, which shows 79% effectiveness in protecting against respiratory syncytial virus (RSV).

Jalisco's Industrial Sector Faces Losses Due to Blackouts
By Sergio Taborga - Fri, 05/31/2024 - 13:32
Jalisco’s industrial sector faces between MX$200 million and MX$250 million in losses from May blackouts, stressing the need for urgent upgrades.
Moderna's Head & Neck Cancer Vaccine Shows Promise
By MBN Staff - Thu, 04/11/2024 - 09:51
Clinical trials combining Moderna's cancer vaccine and Merck’s immunotherapy drug show improved survival rates for head and neck cancer patients.